← All organizations
First clinical trial
Jan 31, 2025Last known activity
Jan 31, 2025
Acquired by Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics on Nov 3, 2023
Timeline
2010s
- Oct 9, 2019
Korro Bio— Founded
2020s
- Jul 14, 2023
Frequency Therapeutics— Acquired
- Nov 3, 2023
Frequency Therapeutics— Acquired By
- Nov 3, 2023
Drugs by trial phase (3 distinct, 8 trials)
Subsidiaries (1 direct, 25 total across the full acquisition tree)
- Frequency Therapeutics
- Korro Bio L2
- Frequency Therapeutics L3
- Korro Bio L4
- Frequency Therapeutics L5
- Korro Bio L6
- Frequency Therapeutics L7
- Korro Bio L8
- Frequency Therapeutics L9
- Korro Bio L10
- Frequency Therapeutics L11
- Korro Bio L12
- Frequency Therapeutics L13
- Korro Bio L14
- Frequency Therapeutics L15
- Korro Bio L16
- Frequency Therapeutics L17
- Korro Bio L18
- Frequency Therapeutics L19
- Korro Bio L20
- Frequency Therapeutics L21
- Korro Bio L22
- Frequency Therapeutics L23
- Korro Bio L24
- Frequency Therapeutics L25
Recent trials (2)
- NCT06677307Lead sponsorPhase 1/Phase 2Jan 31, 2025
- NCT06677307OfficialPhase 1/Phase 2Jan 31, 2025
Details
- Founded
- Boston, MA, US Oct 9, 2019
- Last known activity
- Jan 31, 2025